Salvage radiotherapy is effective in patients with PSMA-PET-negative biochemical recurrence- results of a retrospective study

The present study aimed to assess whether SRT to the prostatic fossa should be initiated in a timely manner after detecting biochemical recurrence (BR) in patients with prostate cancer, when no correlate was identified with prostate-specific membrane antigen positron emission tomography (PSMA-PET).

Bibliographic Details

Main Authors:	Scharl, Sophia Anna Katharina (Author) , Körber, Stefan A. (Author) , Debus, Jürgen (Author)
Format:	Article (Journal)
Language:	English
Published:	July 2023
In:	Radiotherapy and oncology Year: 2023, Volume: 184, Pages: 1-8
ISSN:	1879-0887
DOI:	10.1016/j.radonc.2023.109678
Online Access:	Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.radonc.2023.109678 Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0167814023002165
Author Notes:	Sophia Scharl, Constantinos Zamboglou, Iosif Strouthos, Andrea Farolfi, Francesca Serani, Helena Lanzafame, Alessio Giuseppe Morganti, Christian Trapp, Stefan A. Koerber, Jürgen Debus, Jan C. Peeken, Marco M. E. Vogel, Alexis Vrachimis, Simon K. B. Spohn, Juri Ruf, Anca-Ligia Grosu, Francesco Ceci, Wolfgang P. Fendler, Peter Bartenstein, Stephanie G. C. Kroeze, Matthias Guckenberger, Manuel Krafcsik, Christina Klopscheck, Stefano Fanti, George Hruby, Louise Emmett, Claus Belka, Christian Stief, Nina-Sophie Schmidt-Hegemann, Christoph Henkenberens, Benjamin Mayer, Jonathan Miksch, Mohamed Shelan, Daniel M. Aebersold, Reinhard Thamm, Thomas Wiegel